SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000920465-20-000098
Filing Date
2020-06-22
Accepted
2020-06-22 08:50:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 8-K a20208-k22june2020.htm SC TO-C 32465
2 EXHIBIT 99.1 ex991_ljpcxtetraphasetoppi.htm EX-99.1 8385
3 ljpc8kimages0002.jpg GRAPHIC 6330
4 ljpclogo.jpg GRAPHIC 13518
  Complete submission text file 0000920465-20-000098.txt   69967
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-87366 | Film No.: 20977280
SIC: 2834 Pharmaceutical Preparations